These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1773911)

  • 21. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
    Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
    Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between the effect of glibenclamide and captopril on experimentally induced diabetic nephropathy in rats.
    Akbar DH; Hagras MM; Amin HA; Khorshid OA
    J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):103-15. PubMed ID: 23077081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The kidney as a target organ in diabetic patients with arterial hypertension].
    Viberti G
    Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.
    Bakris GL; Weir MR; DeQuattro V; McMahon FG
    Kidney Int; 1998 Oct; 54(4):1283-9. PubMed ID: 9767545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.
    Berglund J
    Acta Med Scand Suppl; 1988; 722():1-69. PubMed ID: 3163465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
    Sharma AK; Kanawat DS; Mishra A; Dhakad PK; Sharma P; Srivastava V; Joshi S; Joshi M; Raikwar SK; Kurmi MK; Srinivasan BP
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):410-8. PubMed ID: 23396552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Integrated treatment of traditional Chinese medicine and western medicine for early- and intermediate-stage diabetic nephropathy].
    Zhao L; Lan LG; Min XL; Lu AH; Zhu LQ; He XH; He LJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1052-5. PubMed ID: 17666348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic effect of prostaglandin E1 on diabetic nephropathy: a one-year follow-up study].
    Li PF; Mu YR; Xin Y; Qu Y; Liao L
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):482-5. PubMed ID: 20335115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A trial of the use of Vasaprostan in patients with arteriosclerosis obliterans of the lower extremities].
    Lebedev LV; Dobrynin EV; Luk'ianov IuV; Ignat'ev EI; Afonin DN
    Vestn Khir Im I I Grek; 1993; 150(5-6):151-3. PubMed ID: 8091568
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preliminary results of prostaglandin E1 therapy in peripheral obliterating arteriopathy].
    Pilger E; Juan H
    Wien Klin Wochenschr; 1983 Apr; 95(8):263-6. PubMed ID: 6683910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II receptor blockade reduces salt sensitivity of blood pressure through restoration of renal nitric oxide synthesis in patients with diabetic nephropathy.
    Imanishi M; Okada N; Konishi Y; Morikawa T; Maeda I; Kitabayashi C; Masada M; Shirahashi N; Wilcox CS; Nishiyama A
    J Renin Angiotensin Aldosterone Syst; 2013 Mar; 14(1):67-73. PubMed ID: 22859713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Down-regulation of p38 MAPK and collagen by 1, 25-(OH)2-VD3 in rat models of diabetic nephropathy].
    Xie X; Li Z; Pi M; Wu J; Zeng W; Zuo L; Zha Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):931-5. PubMed ID: 27363275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism.
    Zhou S; Zhao P; Li Y; Deng T; Tian L; Li H
    Eur J Pharmacol; 2014 Oct; 740():9-14. PubMed ID: 25008071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of prostaglandin E1 in chronic obliterative diseases of peripheral arteries].
    Zhang GS
    Zhonghua Wai Ke Za Zhi; 1988 Sep; 26(9):541-2, 573. PubMed ID: 3243146
    [No Abstract]   [Full Text] [Related]  

  • 37. Glycaemic control in diabetic nephropathy.
    Bending JJ; Pickup JC; Viberti GC; Keen H
    Br Med J (Clin Res Ed); 1984 Apr; 288(6425):1187-91. PubMed ID: 6424782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy.
    Kadian S; Mahadevan N; Balakumar P
    Eur J Pharmacol; 2013 Jan; 698(1-3):388-96. PubMed ID: 23085026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.